Propofol and Remifentanyl Versus Midazolam and Fentanyl for Diagnostic Colonoscopy in Patients With Compensated Cirrhosis Child A-B

Mise à jour : Il y a 4 ans
Référence : NCT01148277

Femme et Homme

  • | Pays :
  • Israel
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This is a prospective, randomized-controlled trial (RCT) comparing the use of Propofol and Remifentanyl and traditional sedation (Midazolam and Fentanyl) for diagnostic colonoscopies in patients with compensated cirrhosis child A-B. The working hypothesis is that the use of propofol will be translated in a shorter recovery and discharge times with a higher patient satisfaction and a decrease in general complications (Hepatic Encephalopathy) in the context of patients with advanced liver disease.


Critère d'inclusion

  • Liver Disease

Liens